Stephen Ross

Also affiliated with University of California, San Francisco, Neurosciences Institute, Multidisciplinary Association for Psychedelic Studies, Bellevue Hospital Center, Clinical Trial Investigators, Behavioral Health Research Center of the Southwest, Arizona State University, New York University

Social SciencesPsychologyAgricultural and Biological SciencesEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder”.

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder

JAMA Psychiatry(2022)10.1001/jamapsychiatry.2022.2096

N/A

6.1DataRank · unranked

670 citations

Stephen Ross, Snehal Bhatt, Tara Baron, Alyssa A. Forcehimes, Eugene Laska +8 more

Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.106976

N/A

0.761DataRank · unranked

24 citations

Sarah E. Mennenga, Lindsey T. Owens, Samantha K. Podrebarac, Tara Baron, John Rotrosen +4 more

Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer

Nature Mental Health(2024)10.1038/s44220-024-00331-0

N/A

0.360DataRank · unranked

10 citations

Jack Grinband, Gabrielle Agin-Liebes, Connor J. Kinslow, Richard J. Zeifman, Michael P. Bogenschutz +3 more

If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics

Journal of Pain(2022)10.1016/j.jpain.2022.05.003

N/A

0DataRank · unranked

22 citations

B. Anderson, Nick Andrews, Robert R. Edwards, Charles S. Grob, Stephen Ross +3 more

Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs

Neuropharmacology(2023)10.1016/j.neuropharm.2023.109528

N/A

0DataRank · unranked

28 citations

Michael H. Baumann, Sean J. Belouin, Robert H. Dworkin, Majid H. Ghauri, Peter S. Hendricks +5 more

Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion

Research Square(2025)10.21203/rs.3.rs-7420529/v1

N/A

0DataRank · unranked

2 citations

George Danias, Gabrielle Agin-Liebes, Broc A. Pagni, Hannes Kettner, Venkat Bhat +4 more